Healthcare - Biotechnology - NASDAQ - US
$ 7.62
-1.04 %
$ 58.5 M
Market Cap
19.54
P/E
INCOME STATEMENT
48.7 M
REVENUE
-43.7 M
OPERATING INCOME
-61.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Precision BioSciences, Inc.
| Revenue | 48.7 M |
| Cost Of Revenue | 8.26 M |
| Gross Profit | 40.5 M |
| Operating Expenses | 92.5 M |
| Operating Income | -43.7 M |
| Other Expenses | 17.6 M |
| Net Income | -61.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 48.7 | 25.1 | 115.5 | 24.3 | 22.2 | 10.9 | 6.5 | 7.0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 8.3 | 9.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 40.5 | 16.1 | 115.5 | 24.3 | 22.2 | 10.9 | 6.5 | 7.0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 92.5 | 125.5 | 154.9 | 134.1 | 109.4 | 58.8 | 28.3 | 15.2 |
| Selling, General and Administrative Expenses | 39.1 | 41.5 | 39.7 | 36.1 | 27.0 | 13.7 | 8.0 | 6.1 |
| Research and Development Expenses | 49.4 | 83.9 | 115.2 | 98.1 | 82.4 | 45.1 | 20.3 | 9.1 |
| Operating Income | (43.7) | (100.4) | (39.4) | (109.8) | (87.2) | (47.9) | (22.0) | (8.8) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 2.2 | 1.1 | 0.1 | 0 | 0.2 | 0 | 0 | 0 |
| Total Other Income | 1.2 | 27.5 | 8.8 | 0.8 | (5.7) | 1.9 | 0.9 | 0.6 |
| Pre-Tax Income | (42.5) | (111.6) | (30.6) | (109.0) | (92.9) | (46.0) | (21.1) | (8.3) |
| NET INCOME | ||||||||
| Tax Provision | 0 | 11.3 | 0.3 | 10.4 | (9.6) | 1.9 | (0.8) | 5 K |
| Net Income | (61.3) | (122.9) | (30.9) | (109.0) | (83.3) | (46.0) | (21.1) | (8.3) |
| EPS | 16 | 42 | 15.8 | 62.9 | 59.5 | 28.2 | 18.8 | 0.0049 |